http://orcid.org/0000-0002-2899-9755
Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alessandro Rizzo, Raffaella Massafra, Annarita Fanizzi, Lucia Rinaldi, Antonio Cusmai, Agnese Latorre, Gian Maria Zaccaria, Maria Ronchi, Michele Telegrafo, Gennaro Gadaleta-Caldarola, Francesco Giotta, Vito Lorusso & Gennaro Palmiotti. (2022) Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer. Expert Opinion on Investigational Drugs 31:7, pages 707-713.
Read now
Read now
Jianmin Zhang, Fang Wang, Haihui Zhang & Mingbo Cao. (2021) A novel circular RNA circ_HN1/miR-628-5p/Ecto-5’-nucleotidase competing endogenous RNA network regulates gastric cancer development. Bioengineered 12:2, pages 9739-9752.
Read now
Read now
Articles from other publishers (85)
Zahra Shafaghat, Amir-Hossein Khosrozadeh Ghomi, Hossein Khorramdelazad & Elaheh Safari. (2023) Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies. Inflammopharmacology 31:6, pages 3005-3020.
Crossref
Crossref
Mingxue Zhang, Xiaoqin Dai, Yu Xiang, Linshen Xie, Minghan Sun & Jianyou Shi. (2023) Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds. European Journal of Medicinal Chemistry 258, pages 115546.
Crossref
Crossref
Jiadai Xu, Yawen Wang, Panpan Li, Chen Chen, Zhihong Jiang, Xiaona Wang & Peng Liu. (2023)
PRUNE1
(located on chromosome 1q21.3) promotes multiple myeloma with 1q21 Gain by enhancing the links between purine and mitochondrion
. British Journal of Haematology.
Crossref
Crossref
Han Han, Lei Xing, Bi-Te Chen, Yang Liu, Tian-Jiao Zhou, Yi Wang, Ling-Feng Zhang, Ling Li, Chong-Su Cho & Hu-Lin Jiang. (2023) Progress on the pathological tissue microenvironment barrier-modulated nanomedicine. Advanced Drug Delivery Reviews 200, pages 115051.
Crossref
Crossref
Pélagie Mougola Bissiengou, Jérôme Gaston Montcho Comlan, Gabrielle Atsame Ebang, Maguette Sylla Niang & Joel Fleury Djoba Siawaya. (2023)
Prostate malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of
CD8
+ T lymphocytes,
NK
‐cells, and high frequency of
CD73
+ stromal cells
. Cancer Reports 6:S1.
Crossref
Crossref
Shuo Yang, Guoli Li, Xin Yin, Yufei Wang, Xinju Jiang, Xiulan Bian, Tianyi Fang, Shengjie Yin, Lei Zhang & Yingwei Xue. (2023)
Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (
GFPT2
) is a prognostic marker in gastric cancer
. The Journal of Pathology: Clinical Research 9:5, pages 391-408.
Crossref
Crossref
Ulrike Lischetti, Aizhan Tastanova, Franziska Singer, Linda Grob, Matteo Carrara, Phil F. Cheng, Julia M. Martínez Gómez, Federica Sella, Veronika Haunerdinger, Christian Beisel & Mitchell P. Levesque. (2023) Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma. Communications Biology 6:1.
Crossref
Crossref
Máté Posta & Balázs Győrffy. (2023) Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors. Clinical and Translational Science 16:8, pages 1479-1491.
Crossref
Crossref
Brian Effer, Isabela Perez, Daniel Ulloa, Carolyn Mayer, Francisca Muñoz, Diego Bustos, Claudio Rojas, Carlos Manterola, Luis Vergara-Gómez, Camila Dappolonnio, Helga Weber & Pamela Leal. (2023) Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging. Biomedicines 11:7, pages 2086.
Crossref
Crossref
Niklas Bach, Riekje Winzer, Eva Tolosa, Walter Fiedler & Franziska Brauneck. (2023) The Clinical Significance of CD73 in Cancer. International Journal of Molecular Sciences 24:14, pages 11759.
Crossref
Crossref
Lu-Lu Yu, Qi Xiao, Bing Yu, Qiao-Li Lv, Zhao-Qian Liu & Ji-Ye Yin. (2023) CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity. Cancer Letters 564, pages 216219.
Crossref
Crossref
Harsha Rohira, Aditi Arora, Prasanjeet Kaur & Archana Chugh. (2023) Peptide cargo administration: current state and applications. Applied Microbiology and Biotechnology 107:10, pages 3153-3181.
Crossref
Crossref
Chenglai Xia, Shuanghong Yin, Kenneth K. W. To & Liwu Fu. (2023) CD39/CD73/A2AR pathway and cancer immunotherapy. Molecular Cancer 22:1.
Crossref
Crossref
Liping Guan, Qian Hao, Fenfen Shi, Bo Gao, Mengxin Wang, Xiang Zhou, Tao Han & Wenjie Ren. (2023) Regulation of the tumor immune microenvironment by cancer-derived circular RNAs. Cell Death & Disease 14:2.
Crossref
Crossref
Huisheng Li, Peng Xie, Ping Li, Yuheng Du, Jiajia Zhu, Yudong Yuan, Chao Wu, Yantao Shi, Zhiyong Huang, Xudong Wang, Dongying Liu & Weishuai Liu. (2022) CD73/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of Cancers. Advanced Biology 7:2.
Crossref
Crossref
Xuan Jiang, Xiaofang Wu, Yuxi Xiao, Penglin Wang, Jiamian Zheng, Xiuli Wu & Zhenyi Jin. (2023) The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy. Frontiers in Immunology 14.
Crossref
Crossref
Liying Li, Fan Zhang, Zhenyu Liu & Zhimin Fan. (2023) Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome. Cancers 15:1, pages 321.
Crossref
Crossref
Pooja Kumari, Preeti Sharma, Yogesh Srivastava & Narendra Kumar Sharma. 2023. Smart Nanomaterials Targeting Pathological Hypoxia. Smart Nanomaterials Targeting Pathological Hypoxia
59
80
.
Yousef Yousefzadeh, Mohammad Sadegh Soltani-Zangbar, Ladan Kalafi, Ali Tarbiat, Sima Shahmohammadi Farid, Leili Aghebati-Maleki, Forough Parhizkar, Shahla Danaii, Simin Taghavi, Farhad Jadidi-Niaragh, Hossein Samadi Kafil, Ata Mahmoodpoor, Javad Ahmadian Heris, Mohammad Hojjat-Farsangi & Mehdi Yousefi. (2022) Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women. Molecular Biology Reports 49:11, pages 10183-10193.
Crossref
Crossref
Mukhtar Ahmad Dar, Pawan Kumar, Prakash Kumar, Ashish Shrivastava, Muneer Ahmad Dar, Richa Chauhan, Vinita Trivedi, Ashutosh Singh, Eshan Khan, Ravichandiran Velayutham & Sameer Dhingra. (2022) Designing of Peptide Based Multi-Epitope Vaccine Construct against Gallbladder Cancer Using Immunoinformatics and Computational Approaches. Vaccines 10:11, pages 1850.
Crossref
Crossref
Nazeer Ahmad Khan, Faisal Rashid, Muhammad Siraj Khan Jadoon, Saquib Jalil, Zulfiqar Ali Khan, Raha Orfali, Shagufta Perveen, Areej Al-Taweel, Jamshed Iqbal & Sohail Anjum Shahzad. (2022) Design, Synthesis, and Biological Evaluation of Novel Dihydropyridine and Pyridine Analogs as Potent Human Tissue Nonspecific Alkaline Phosphatase Inhibitors with Anticancer Activity: ROS and DNA Damage-Induced Apoptosis. Molecules 27:19, pages 6235.
Crossref
Crossref
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti-Mays & Zihai Li. (2022) Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Yifan Ren, Jialong Song, Xinyi Li & Na Luo. (2022) Rationale and Clinical Research Progress on PD-1/PD-L1-Based Immunotherapy for Metastatic Triple-Negative Breast Cancer. International Journal of Molecular Sciences 23:16, pages 8878.
Crossref
Crossref
Xiao Guan, Na Lu & Jianping Zhang. (2022) The combined prognostic model of copper-dependent to predict the prognosis of pancreatic cancer. Frontiers in Genetics 13.
Crossref
Crossref
Lin Zhang, Chao Zhou, Songou Zhang, Xiaozhen Chen, Jian Liu, Fangming Xu & Wenqing Liang. (2022) Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors. Frontiers in Oncology 12.
Crossref
Crossref
Zhenni Liu, Xue Wu, Qi Wang, Zixuan Li, Xueqi Liu, Xiaodong Sheng, Hong Zhu, Mengda Zhang, Junrui Xu, Xiaowen Feng, Baoming Wu & Xiongwen Lv. (2022) CD73-Adenosine A1R Axis Regulates the Activation and Apoptosis of Hepatic Stellate Cells Through the PLC-IP3-Ca2+/DAG-PKC Signaling Pathway. Frontiers in Pharmacology 13.
Crossref
Crossref
Félix Grosjean, Emeline Cros‐Perrial, Abdenour Braka, Jean‐Pierre Uttaro, Laurent Chaloin, Lars Petter Jordheim, Suzanne Peyrottes & Christophe Mathé. (2021) Synthesis and Studies of Potential Inhibitors of CD73 Based on a Triazole Scaffold. European Journal of Organic Chemistry 2022:21.
Crossref
Crossref
Pengcheng Sun, Xiao Zheng & Xiaodong Li. (2022) The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment. Journal of Oncology 2022, pages 1-8.
Crossref
Crossref
Lin Zhu, Xinwei Kuang, Guanxiong Zhang, Long Liang, Dandan Liu, Bin Hu, Zuozhong Xie, Hui Li, Hong Liu, Mao Ye, Xiang Chen & Jing Liu. (2022) Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation. Journal for ImmunoTherapy of Cancer 10:5, pages e003819.
Crossref
Crossref
Yaoting Zhang, Sultan Kadasah, Jiaheng Xie & Dongsheng Gu. (2022) Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker. Applied Bionics and Biomechanics 2022, pages 1-14.
Crossref
Crossref
Yicun Jiang, Leilei Zhao, Yiwen Wu, Sijun Deng, Pu Cao, Xiaoyong Lei & Xiaoyan Yang. (2022) The Role of NcRNAs to Regulate Immune Checkpoints in Cancer. Frontiers in Immunology 13.
Crossref
Crossref
Yanming Zhang, Shuang Ye, Yuan Wang, Chuanhao Wang, Yazhao Zhu, Yuelin Wu, Yongqiang Zhang, Huojun Zhang & Zhenyuan Miao. (2022) Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors. Bioorganic & Medicinal Chemistry 59, pages 116672.
Crossref
Crossref
Ying Zhou, Eric Wai‐Choi Tse, Rock Leung, Edwin Cheung, Hongyan Li & Hongzhe Sun. (2021) Multiplex Single‐Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B‐ALL. ChemMedChem 17:3.
Crossref
Crossref
Fariba Karoon Kiani, Sepideh Izadi, Ehsan Ansari Dezfouli, Farbod Ebrahimi, Mohammad Mohammadi, Hengameh Chalajour, Mirmohammad Mortazavi Bulus, Maryam Nasr Esfahani, Vahid Karpisheh, Armin Mahmoud Salehi Khesht, Kazem Abbaszadeh-Goudarzi, Ali Soleimani, Jamshid Gholizadeh Navashenaq, Majid Ahmadi, Hadi Hassannia, Mohammad Hojjat-Farsangi, Sima Shahmohammadi Farid, Vida Hashemi & Farhad Jadidi-Niaragh. (2022) Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models. Life Sciences 288, pages 120166.
Crossref
Crossref
Manzoor A. Mir, Shariqa Aisha & Umar Mehraj. 2022. Combinational Therapy in Triple Negative Breast Cancer. Combinational Therapy in Triple Negative Breast Cancer
61
94
.
Sumit Dey & Ravimohan S. Mavuduru. 2022. Biomedical Translational Research. Biomedical Translational Research
367
391
.
Ya-Ping Xu, Ze-Ning Dong, Si-Wei Wang, Yi-Min Zheng, Chi Zhang, Ying-Qun Zhou, Yu-Jie Zhao, Yan Zhao, Feng Wang, Rui Peng, Mao-Chun Tang, Dou-sheng Bai, Xiao-Yong Huang & Chuan-Yong Guo. (2021) circHMGCS1–016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Ida Friberger, Emma Jussing, Jinming Han, Jeroen A. C. M. Goos, Jonathan Siikanen, Helen Kaipe, Mélanie Lambert, Robert A. Harris, Erik Samén, Mattias Carlsten, Staffan Holmin & Thuy A. Tran. (2021) Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications. Molecular Imaging and Biology 23:6, pages 952-962.
Crossref
Crossref
Hongjie Shi, Linzhi Han, Jinping Zhao, Kaijie Wang, Ming Xu, Jiajun Shi & Zhe Dong. (2021) Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma. Cancer Medicine 10:24, pages 8944-8960.
Crossref
Crossref
Francesca Cersosimo, Marcella Barbarino, Silvia Lonardi, William Vermi, Antonio Giordano, Cristiana Bellan & Emanuele Giurisato. (2021) Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms. Cancers 13:22, pages 5664.
Crossref
Crossref
Melanie Wurm, Otmar Schaaf, Katharina Reutner, Rajkumar Ganesan, Sven Mostböck, Christina Pelster, Jark Böttcher, Bruna de Andrade Pereira, Christina Taubert, Isabella Alt, Garazi Serna, Aurelie Auguste, Kai B. Stadermann, Denis Delic, Fei Han, Jaume Capdevila, Paolo G. Nuciforo, Rachel Kroe-Barrett, Paul J. Adam, Anne B. Vogt & Irmgard Hofmann. (2021) A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway. Molecular Cancer Therapeutics 20:11, pages 2250-2261.
Crossref
Crossref
Jun Wang, Jing Liu & Zhongxing Yang. (2021) Recent advances in peptide-based nanomaterials for targeting hypoxia. Nanoscale Advances 3:21, pages 6027-6039.
Crossref
Crossref
Yongjun Sun, Jie Ma, Junkai Lin, Dawei Sun, Ping Song, Lujing Shi, Hongtao Li, Ruijie Wang, Ziwen Wang & Shijun Liu. (2021) Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis. Anti-Cancer Drugs 32:9, pages 950-961.
Crossref
Crossref
Shahin Hallaj, Mohammad Mirza-Aghazadeh-Attari, Amin Arasteh, Anahita Ghorbani, Daniel Lee & Farhad Jadidi-Niaragh. (2021) Adenosine: The common target between cancer immunotherapy and glaucoma in the eye. Life Sciences 282, pages 119796.
Crossref
Crossref
María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud & Vanina A. Medina. (2021) Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacology Research & Perspectives 9:5.
Crossref
Crossref
Cristina Prat-Vidal, Verónica Crisóstomo, Isabel Moscoso, Claudia Báez-Díaz, Virginia Blanco-Blázquez, Guadalupe Gómez-Mauricio, Guillermo Albericio, Susana Aguilar, María-Eugenia Fernández-Santos, Francisco Fernández-Avilés, Francisco M. Sánchez-Margallo, Antoni Bayes-Genis & Antonio Bernad. (2021) Intracoronary Delivery of Porcine Cardiac Progenitor Cells Overexpressing IGF-1 and HGF in a Pig Model of Sub-Acute Myocardial Infarction. Cells 10:10, pages 2571.
Crossref
Crossref
Rikke Sick Andersen, Atul Anand, Dylan Scott Lykke Harwood & Bjarne Winther Kristensen. (2021) Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy. Cancers 13:17, pages 4255.
Crossref
Crossref
Yichi Xu, Gendi Song, Shangdan Xie, Wenxiao Jiang, Xin Chen, Man Chu, Xiaoli Hu & Zhi-wei Wang. (2021) The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer. Molecular Therapy 29:6, pages 1958-1969.
Crossref
Crossref
Sima Emadi Allahyari, Farnaz Hajizadeh, Angelina Olegovna Zekiy, Niloofar Mansouri, Parisa Sahami Gilan, Seyedeh Mahboubeh Mousavi, Ali Masjedi, Hadi Hassannia, Majid Ahmadi, Hamed Mohammadi, Mehdi Yousefi, Sepideh Izadi, Naime Majidi Zolbanin, Reza Jafari & Farhad Jadidi-Niaragh. (2021) Simultaneous inhibition of CD73 and IL-6 molecules by siRNA-loaded nanoparticles prevents the growth and spread of cancer. Nanomedicine: Nanotechnology, Biology and Medicine 34, pages 102384.
Crossref
Crossref
Qiong Li, Huifang Hou, Meng Li, Xia Yu, Hongbo Zuo, Jianhui Gao, Min Zhang, Zongjin Li & Zhikun Guo. (2021) CD73+ Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Mohammad Hossein Kazemi, Alireza Najafi, Jafar Karami, Foad Ghazizadeh, Hassan Yousefi, Reza Falak & Elahe Safari. (2021) Immune and metabolic checkpoints blockade: Dual wielding against tumors. International Immunopharmacology 94, pages 107461.
Crossref
Crossref
Ernest Osei, Stephanie Swanson, Lyba Sheraz & Nada Khaled Fouad Ibrahim. (2021) Review of novel tissue-based biomarkers for prostate cancer: towards personalised and targeted medicine. Journal of Radiotherapy in Practice, pages 1-10.
Crossref
Crossref
Marie-Claire Rittmann, Saskia Hussung, Lukas M. Braun, Rhena F. U. Klar, Esther A. Biesel, Stefan Fichtner-Feigl, Ralph Fritsch, Uwe A. Wittel & Dietrich A. Ruess. (2021) Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma. Scientific Reports 11:1.
Crossref
Crossref
Rayane Ghoteimi, Abdennour Braka, Céline Rodriguez, Emeline Cros-Perrial, Van Tai Nguyen, Jean-Pierre Uttaro, Christophe Mathé, Laurent Chaloin, Christine Ménétrier-Caux, Lars Petter Jordheim & Suzanne Peyrottes. (2021) 4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies. Bioorganic Chemistry 107, pages 104577.
Crossref
Crossref
Jiaxin Liu, Yicheng Cheng, Ming Zheng, Bingxiao Yuan, Zimu Wang, Xinying Li, Jie Yin, Mingxiang Ye & Yong Song. (2021) Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Khalid Odamizil Alzamely, Farnaz Hajizadeh, Morteza Heydari, Mohamad Javad Ghaderi Sede, Sima Hydarzadeh Asl, Makwan Peydaveisi, Ali Masjedi, Sepideh Izadi, Afshin Nikkhoo, Fatemeh Atyabi, Afshin Namdar, Behzad Baradaran, Mozhdeh Sojoodi & Farhad Jadidi-Niaragh. (2021) Combined inhibition of CD73 and ZEB1 by Arg-Gly-Asp (RGD)-targeted nanoparticles inhibits tumor growth. Colloids and Surfaces B: Biointerfaces 197, pages 111421.
Crossref
Crossref
Ishwar Navin, Michael T. Lam & Robin Parihar. (2020) Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment. Cancers 12:12, pages 3871.
Crossref
Crossref
Zhenzhen Yang, Jiacheng Guo, Lanling Weng, Wenxue Tang, Shuiling Jin & Wang Ma. (2020) Myeloid-derived suppressor cells—new and exciting players in lung cancer. Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Jianguo Zhang, Jianzhong Zhang, Cheng Yuan, Yuan Luo, Yangyi Li, Panpan Dai, Wenjie Sun, Nannan Zhang, Jiangbo Ren, Junhong Zhang, Yan Gong & Conghua Xie. (2020) Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis. Cancer Cell International 20:1.
Crossref
Crossref
Mitra Ghasemi‐Chaleshtari, Seyed Hossein Kiaie, Mahzad Irandoust, Hadis Karami, Mohsen Nabi Afjadi, Sepideh Ghani, Nasimeh Aghaei Vanda, Mohammad Javad Ghaderi Sede, Armin Ahmadi, Ali Masjedi, Hadi Hassannia, Fatemeh Atyabi, Mohammad Hojjat‐Farsangi, Afshin Namdar, Ghasem Ghalamfarsa & Farhad Jadidi‐Niaragh. (2020) Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses. Journal of Cellular Physiology 235:12, pages 10068-10080.
Crossref
Crossref
Abbas Hajifathali, Sayeh Parkhideh, Mohammad H. Kazemi, Rouzbeh Chegeni, Elham Roshandel & Majid Gholizadeh. (2020) Immune checkpoints in hematologic malignancies: What made the immune cells and clinicians exhausted!. Journal of Cellular Physiology 235:12, pages 9080-9097.
Crossref
Crossref
Julia Tsiampali, Silke Neumann, Beatriz Giesen, Katharina Koch, Donata Maciaczyk, Christoph Janiak, Daniel Hänggi & Jaroslaw Maciaczyk. (2020) Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming. Pharmaceuticals 13:11, pages 378.
Crossref
Crossref
Ali Masjedi, Armin Ahmadi, Sepideh Ghani, Farinaz Malakotikhah, Mohsen Nabi Afjadi, Mahzad Irandoust, Fariba Karoon Kiani, Sima Heydarzadeh Asl, Fatemeh Atyabi, Hadi Hassannia, Mohammad Hojjat-Farsangi, Afshin Namdar, Ghasem Ghalamfarsa & Farhad Jadidi-Niaragh. (2020) Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 29, pages 102240.
Crossref
Crossref
Farnaz Hajizadeh, Ali Masjedi, Sima Heydarzedeh Asl, Fariba Karoon Kiani, Makwan Peydaveisi, Ghasem Ghalamfarsa, Farhad Jadidi-Niaragh & Andrey Sevbitov. (2020) Adenosine and adenosine receptors in colorectal cancer. International Immunopharmacology 87, pages 106853.
Crossref
Crossref
Xiaohui Du, Jared Moore, Brian R. Blank, John Eksterowicz, Dena Sutimantanapi, Natalie Yuen, Todd Metzger, Brenda Chan, Tom Huang, Xi Chen, Yuping Chen, Frank Duong, Wayne Kong, Jae H. Chang, Jessica Sun, Tatiana Zavorotinskaya, Qiuping Ye, Melissa R. Junttila, Chudi Ndubaku, Lori S. Friedman, Valeria R. Fantin & Daqing Sun. (2020) Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production. Journal of Medicinal Chemistry 63:18, pages 10433-10459.
Crossref
Crossref
Farnaz Hajizadeh, Sadaf Moghadaszadeh Ardebili, Mahdi Baghi Moornani, Ali Masjedi, Fatemeh Atyabi, Melika Kiani, Afshin Namdar, Vahid Karpisheh, Sepideh Izadi, Behzad Baradaran, Gholamreza Azizi, Ghasem Ghalamfarsa, Gholamabas Sabz, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2020) Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. European Journal of Pharmacology 882, pages 173235.
Crossref
Crossref
Qiangda Chen, Ning Pu, Hanlin Yin, Jicheng Zhang, Guochao Zhao, Wenhui Lou & Wenchuan Wu. (2020) CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer. Journal of Cellular and Molecular Medicine 24:15, pages 8674-8686.
Crossref
Crossref
Sepideh Izadi, Afshin Nikkhoo, Mohammad Hojjat-Farsangi, Afshin Namdar, Gholamreza Azizi, Hamed Mohammadi, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2020) CDK1 in Breast Cancer: Implications for Theranostic Potential. Anti-Cancer Agents in Medicinal Chemistry 20:7, pages 758-767.
Crossref
Crossref
Yousef Yousefzadeh, Shahin Hallaj, Mahdi Baghi Moornani, Amir Asghary, Gholamreza Azizi, Mohammad Hojjat-Farsangi, Ghasem Ghalamfarsa & Farhad Jadidi-Niaragh. (2020) Tumor associated macrophages in the molecular pathogenesis of ovarian cancer. International Immunopharmacology 84, pages 106471.
Crossref
Crossref
Sevda Salimifard, Ali Masjedi, Mohammad Hojjat-Farsangi, Ghasem Ghalamfarsa, Mahzad Irandoust, Gholamreza Azizi, Hamed Mohammadi, Mohammad Reza Keramati & Farhad Jadidi-Niaragh. (2020) Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathology - Research and Practice 216:5, pages 152915.
Crossref
Crossref
Jinjoo Park & Kwang-Hoon Chun. (2020) Identification of novel functions of the ROCK2-specific inhibitor KD025 by bioinformatics analysis. Gene 737, pages 144474.
Crossref
Crossref
Shima Bastaki, Mahzad Irandoust, Armin Ahmadi, Mohammad Hojjat-Farsangi, Patrick Ambrose, Shahin Hallaj, Mahdi Edalati, Ghasem Ghalamfarsa, Gholamreza Azizi, Mehdi Yousefi, Hengameh Chalajour & Farhad Jadidi-Niaragh. (2020) PD-L1/PD-1 axis as a potent therapeutic target in breast cancer. Life Sciences 247, pages 117437.
Crossref
Crossref
Ali Masjedi, Armin Ahmadi, Fatemeh Atyabi, Shohreh Farhadi, Mahzad Irandoust, Yalda Khazaei-Poul, Mitra Ghasemi Chaleshtari, Mahdi Edalati Fathabad, Masoumeh Baghaei, Navideh Haghnavaz, Behzad Baradaran, Mohammad Hojjat-Farsangi, Ghasem Ghalamfarsa, Gholamabas Sabz, Sajad Hasanzadeh & Farhad Jadidi-Niaragh. (2020) Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. International Journal of Biological Macromolecules 149, pages 487-500.
Crossref
Crossref
Marta Schmidt Pfaffenzeller, Maria Luiza Mukai Franciosi & Andréia Machado Cardoso. (2020) Purinergic signaling and tumor microenvironment in cervical Cancer. Purinergic Signalling 16:1, pages 123-135.
Crossref
Crossref
Vida Hashemi, Leili Aghebati Maleki, Maryam Esmaily, Ali Masjedi, Ghasem Ghalamfarsa, Afshin Namdar, Mehdi Yousefi, Bahman Yousefi & Farhad Jadidi-Niaragh. (2020) Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target. International Immunopharmacology 78, pages 106087.
Crossref
Crossref
Brian Hutzen, Mohammed Ghonime, Joel Lee, Elaine R. Mardis, Ruoning Wang, Dean A. Lee, Mitchell S. Cairo, Ryan D. Roberts, Timothy P. Cripe & Kevin A. Cassady. (2019) Immunotherapeutic Challenges for Pediatric Cancers. Molecular Therapy - Oncolytics 15, pages 38-48.
Crossref
Crossref
Farhad Jadidi-Niaragh. (2019) Potential of CD73 as a target for cancer immunotherapy. Immunotherapy 11:16, pages 1353-1355.
Crossref
Crossref
Farnaz Hajizadeh, Isobel Okoye, Maryam Esmaily, Mitra Ghasemi Chaleshtari, Ali Masjedi, Gholamreza Azizi, Mahzad Irandoust, Ghasem Ghalamfarsa & Farhad Jadidi-Niaragh. (2019) Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sciences 237, pages 116952.
Crossref
Crossref
Seyed Mohammad Hosseini, Isobel Okoye, Mitra Ghasemi Chaleshtari, Bita Hazhirkarzar, Javad Mohamadnejad, Gholamreza Azizi, Mohammad Hojjat-Farsangi, Hamed Mohammadi, Siamak Sandoghchian Shotorbani & Farhad Jadidi-Niaragh. (2019) E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions. Clinica Chimica Acta 498, pages 126-134.
Crossref
Crossref
Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat-Farsangi, Afshin Namdar, Gholamreza Azizi, Ghasem Ghalamfarsa, Gholamabas Sabz, Mehdi Yousefi, Bahman Yousefi & Farhad Jadidi-Niaragh. (2019) Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer. Prostaglandins & Other Lipid Mediators 144, pages 106338.
Crossref
Crossref
Siqi Chen, Derek A Wainwright, Jennifer D Wu, Yong Wan, Daniela E Matei, Yi Zhang & Bin Zhang. (2019) CD73: an emerging checkpoint for cancer immunotherapy. Immunotherapy 11:11, pages 983-997.
Crossref
Crossref
Enja Schneider, Anne Rissiek, Riekje Winzer, Berta Puig, Björn Rissiek, Friedrich Haag, Hans-Willi Mittrücker, Tim Magnus & Eva Tolosa. (2019) Generation and Function of Non-cell-bound CD73 in Inflammation. Frontiers in Immunology 10.
Crossref
Crossref
Andrea M. Chambers & Sandro Matosevic. (2019) Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors. Frontiers in Molecular Biosciences 6.
Crossref
Crossref
Ali Masjedi, Hadi Hassannia, Fatemeh Atyabi, Ali Rastegari, Mohammad Hojjat-Farsangi, Afshin Namdar, Hassan Soleimanpour, Gholamreza Azizi, Afshin Nikkhoo, Ghasem Ghalamfarsa, Abbas Mirshafiey & Farhad Jadidi-Niaragh. (2019) Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway. International Journal of Biological Macromolecules 133, pages 436-445.
Crossref
Crossref
Luc Rochette, Alexandre Meloux, Eve Rigal, Marianne Zeller, Yves Cottin & Catherine Vergely. (2019) The Role of Osteoprotegerin and Its Ligands in Vascular Function. International Journal of Molecular Sciences 20:3, pages 705.
Crossref
Crossref